Peuhu et al. BMC Cancer 2010, 10:521 http://www.biomedcentral.com/1471-2407/10/521 Received: 9 April 2010 Accepted: 3 October 2010 Published: 3 October 2010 References 1. De Fabo EC, Noonan FP: Mechanism of immune suppression by ultraviolet irradiation in vivo. I. evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J Exp Med 1983, 158:84-98. 2. Norval M, El-Ghorr AA: Studies to determine the immunomodulating effects of cis-urocanic acid. Methods 2002, 28:63-70. 3. Laihia JK, Pylkkänen L, Laato M, Boström PJ, Leino L: Protodynamic therapy for bladder cancer In vitro results of a novel treatment concept. BJU Int 2009, 104:1233-1238. 4. Laihia JK, Kallio J, Taimen P, Kujari H, Kähäri V-M, Leino L: Protodynamic intracellular acidification by cis-urocanic acid promotes apoptosis of melanoma cells in vitro and in vivo. J Invest Dermatol , advance online publication, 3 June 2010. 5. Thangaraju M, Sharma K, Liu D, Shen SH, Srikant CB: Interdependent regulation of intracellular acidification and SHP-1 in apoptosis. Cancer Res 1999, 59:1649-1654. 6. Cosentini E, Haberl I, Pertschy P, Teleky B, Mallinger R, Baumgartner G, Wenzl E, Hamilton G: The differentiation inducers phenylacetate and phenylbutyrate modulate camptothecin sensitivity in colon carcinoma cells in vitro by intracellular acidification. Int J Oncol 2001, 19:1069-1074. 7. Gottlieb RA, Nordberg J, Skowronski E, Babior BM: Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci USA 1996, 93:654-658. 8. Matsuyama S, Llopis J, Deveraux QL, Tsien RY, Reed JC: Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol 2000, 2:318-325. 9. Juusola P, Minkkinen P, Leino L, Laihia JK: Determination of the dissociation constants of urocanic acid isomers in aqueous solutions. Monatsh Chem 2007, 138:951-965. 10. Donella-Deana A, MacGowan CH, Cohen P, Marchiori F, Meyer HE, Pinna LA: An investigation of the substrate specificity of protein phosphatase 2C using synthetic peptide substrates; comparison with protein phosphatase 2A. Biochim Biophys Acta 1990, 1051:199-202. 11. Daum G, Solca F, Diltz CD, Zhao Z, Cool DE, Fischer EH: A general peptide substrate for protein tyrosine phosphatases. Anal Biochem 1993, 211:50-54. 12. Zhang ZY, Thieme-Selfer AM, Maclean D, McNamara DJ, Dobrusin EM, Sawyer TK, Dixon JE: Substrate specificity of the protein tyrosine phosphatases. Proc Natl Acad Sci USA 1993, 90:4446-4450. 13. Fujiki H, Suganima M: Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors. Prog Mol Subcell Biol 2009, 46:221-254. 14. Liu D, Chen Z: The effects of cantharidin and cantharidin derivates on tumour cells. Anticancer Agents Med Chem 2009, 9:392-396. 15. Rajesh D, Schell K, Verma AK: Ras mutation, irrespective of cell type and p53 status, determines a cell’s destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. Mol Pharmacol 1999, 56(3):515-525. 16. Knowles MA, Williamson M: Mutation of H-ras is infrequent in bladder cancer: Confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Cancer Res 1993, 53:133-139. 17. Boulalas I, Zaravinos A, Karyotis I, Delakas D, Spandidos DA: Activation of RAS family genes in urothelial carcinoma. J Urol 2009, 181:2312-2319. 18. Tannock IF, Rotin D: Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989, 49:4373-4384. 19. Arentsen HC, Falke J, Jansen CFJ, Hulsbergen-van de Kaa CA, Laihia JK, Pylkkänen L, Leino L, Oosterwijk E, Witjes JA: Antitumour effects of cis- urocanic acid, an intravesical protodynamic drug, in experimental urothelial cell carcinoma of the bladder. Eur Urol Suppl 2010, 9:292. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/10/521/prepub Page 9 of 9 doi:10.1186/1471-2407-10-521 Cite this article as: Peuhu et al.: Molecular targets for the protodynamic action of cis-urocanic acid in human bladder carcinoma cells. BMC Cancer 2010 10:521. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit